25344208Iida M, Brand TM, Starr MM, Huppert EJ, Luthar N, Bahrar H, Coan JP, Pearson HE, Salgia R, Wheeler DLMolecular cancerAntibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Drug Resistance, Neoplasm; Receptor, ErbB-3Animals; Antibodies, Neutralizing; Antineoplastic Agents; Broadly Neutralizing Antibodies; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cetuximab; ErbB Receptors; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Signal Transduction; Xenograft Model Antitumor AssaysOvercoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy. Mol Cancer. 2014 Oct 24; 13:242.Mol Cancer2014-10-24T00:00:002014Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000970Chemicals & Drugs40723510.435461Antineoplastic AgentsD000818Living Beings1457265180.249624AnimalsD000911Chemicals & Drugs33713760.622749Antibodies, MonoclonalD002289Disorders15810730.519149Carcinoma, Non-Small-Cell LungD008819Living Beings2217900.84759Mice, NudeD008175Disorders32822600.404525Lung NeoplasmsD006801Living Beings2262862810.130052HumansD008297Physiology1931408600.201617MaleD019008Physiology1805890.751116Drug Resistance, NeoplasmD049109Physiology43515710.639735Cell ProliferationD020893Chemicals & Drugs14180.984716Receptor, ErbB-3D051379Living Beings980113130.368397MiceD061067Chemicals & Drugs2139290.656166Antibodies, Monoclonal, HumanizedD018719Chemicals & Drugs832230.868888Receptor, ErbB-2D023041Procedures1684580.868544Xenograft Model Antitumor AssaysD019869Chemicals & Drugs1352620.903387Phosphatidylinositol 3-KinasesD045744Anatomy46824210.643233Cell Line, TumorD057134Chemicals & Drugs661120.928716Antibodies, NeutralizingD000068818471130.945048CetuximabD066246Chemicals & Drugs1494850.779528ErbB ReceptorsD015398Physiology69932330.460036Signal TransductionD051057Chemicals & Drugs1483210.870521Proto-Oncogene Proteins c-aktMedicineUniversity of ChicagoRaviSalgiaRavi Salgia41.78927490000000-87.601250000000001937Salgia, RaviEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, ProfessorAuthorship 7148590.130070.130071authors10.2522has subject area